Riskpilot← Back to searchSign inGet full accessParaTech ApS
APSActiveCVR 27971822Vallerød Banevej 12Research and experimental development on natural sciences and engineering · NACE 7210Est. 20043 employees
Revenue 2024
DKK 542K
-28% vs 2023
EBITDA margin
-70.0%
-1743% vs 2023
Equity ratio
91.6%
Financial strength
Net profit 2024
DKK -414K
-108% vs 2023
| Revenue | DKK 542K | -28% |
| EBITDA | DKK -380K | -1743% |
| Net profit | DKK -414K | -108% |
| Total assets | DKK 7,1M | -3% |
| Equity | DKK 6,5M | -6% |
| Employees | 3 | — |
Legal name
ParaTech ApS
CVR number
27971822
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. juli 2004
Share capital
DKK 40.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør eller af alle direktører i forening.
Company purpose
Selskabets formål er kontraktforskning, konsulentydelser og rådgivning inden for biotek- og farmavirksomhed.
Address
Vallerød Banevej 12
Email
chk@para-tech.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.480 | 6.077 | -5 | -1.637 | -818 | -3.115 | -7.229 | -5.251 | -7.239 | -4.833 | -1.158 | 751 | 542 |
| Staff expenses | -1.687 | -3.020 | -3.240 | -408 | -29 | -575 | -962 | -857 | -1.252 | -1.050 | -904 | -772 | -922 |
| EBITDA | 2.793 | 3.057 | -3.246 | -2.045 | -847 | -3.691 | -8.191 | -6.108 | -8.491 | -5.883 | -2.062 | -21 | -380 |
| Depreciation & amort. | -683 | -910 | -846 | -146 | -17 | -0 | -0 | -8 | -54 | -62 | -54 | -25 | -137 |
| EBIT | 2.110 | 2.147 | -4.091 | -2.191 | -864 | -3.691 | -8.191 | -6.116 | -8.545 | -5.945 | -2.116 | -46 | -516 |
| Net financials | -11 | -6 | 9 | -1 | 0 | -10 | -11 | -6 | -27 | -1 | -3 | 5.427 | 24 |
| Profit before tax | 2.099 | 2.141 | -4.082 | -2.192 | -864 | -3.700 | -8.202 | -6.122 | -8.572 | -5.945 | -2.118 | 5.381 | -492 |
| Tax | 525 | 555 | -613 | -370 | -306 | -888 | -1.742 | -1.349 | -1.884 | -1.303 | -612 | 141 | -78 |
| Net profit | 1.574 | 1.586 | -3.469 | -1.822 | -558 | -2.813 | -6.461 | -4.773 | -6.689 | -4.643 | -1.506 | 5.241 | -414 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.161 | 7.838 | 3.246 | 777 | 593 | 5.430 | 4.856 | 9.109 | 8.107 | 3.321 | 2.054 | 7.313 | 7.074 |
| Equity | 4.300 | 5.886 | 2.417 | 595 | 37 | 4.124 | 4.564 | 8.990 | 7.802 | 3.159 | 1.653 | 6.894 | 6.480 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 49 | 0 | 0 | 0 | 0 |
| Short-term debt | 861 | 1.952 | 829 | 182 | 556 | 1.305 | 292 | 107 | 256 | 161 | 401 | 419 | 594 |
| Total debt | 861 | 1.952 | 829 | 182 | 556 | 1.305 | 292 | 119 | 305 | 161 | 401 | 419 | 594 |
EBITDA margin
-70.0%
This company
15.8%
Market median
-543% vs market
20122024
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20122024
Return on equity
-6.4%
This company
18.4%
Market median
-135% vs market
20122024
Net profit margin
-76.3%
This company
8.1%
Market median
-1042% vs market
20122024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20122024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BG Founder | Founder | 2004 | — | — |
CM Management | Management | 2004 | — | — |
HS Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KAPEL HOLDING ApS | Company | 100.0% | 100.0% | 2022 |
ALISTRATHEN ApS | Company | 5.0% | 5.0% | 2019 |
Lodberg Group Holding ApS | Company | 5.0% | 5.0% | 2019 |
| Individual | 25.0% | 25.0% | 2012 | |
C. HANSEN INVEST ApS | Company | 5.0% | 5.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KAPEL HOLDING ApS
ParaTech ApS Board members of ParaTech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| BioCure Gmbh | Founder | 0 companies |
| Christian Moliin Outzen Kapel | Management | 0 companies |
| Hanne Schultz Kapel | Management | 0 companies |
| Lars Lüthjohan | Chairman | 0 companies |
| Esper Boel | Board of Directors | 0 companies |
| Allan Knud Roepstorff | Board of Directors | 0 companies |
| Christian Karsten Hansen | Board of Directors | 0 companies |
| Sune Reinholth Nyland | Chairman | 0 companies |
| Stig Milan Thamsborg | Board of Directors | 0 companies |